Skip to main content
Terug
Watch Compare

Arcadia Biosciences, Inc.

Datakwaliteit: 100%
RKDA
Nasdaq Energy Oil & Gas Extraction
€ 1,34
▲ € 0,01 (0,75%)
Marktkapitalisatie: 2,76 M
Prijs
€ 1,34
Marktkapitalisatie
2,76 M
Dagbereik
€ 1,33 — € 1,38
52-Weeksbereik
€ 1,30 — € 6,71
Volume
7.500
Openen € 1,37
50D / 200D Gem.
€ 1,81
25,91% below
50D / 200D Gem.
€ 3,28
59,15% below

Quick Summary

Belangrijkste Punten

Revenue declined -8,00% annually over 5 years
Negative free cash flow of -4,74 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,29%
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
-8,00%
Onder sectorgemiddelde (9,32%)
Revenue (1Y)-3,71%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-46,89%
Onder sectorgemiddelde (3,47%)
ROIC-32,25%
Net Margin-48,15%
Op. Margin-51,46%

Veiligheid

Debt / Equity
N/A
Current Ratio3,67
Interest Coverage-11,31

Waardering

PE (TTM)
-1,18
Onder sectorgemiddelde (3,38)
P/B Ratio0,51
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Energy sector mediaan (539 peers)
Metriek Aandeel Sector Mediaan
P/E -1,2 3,4
P/B 0,5 2,1
ROE % -46,9 3,5
Net Margin % -48,2 4,9
Rev Growth 5Y % -8,0 9,3
D/E — 0,5

All Fundamental Metrics
Growth
Revenue Growth (1Y) -3,71% Revenue Growth (3Y) -4,53%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8,00% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4,86 M Net Income (TTM) -2,34 M
ROE -46,89% ROA -28,57%
Gross Margin N/A Operating Margin -51,46%
Net Margin -48,15% Free Cash Flow (TTM) -4,74 M
ROIC -32,25% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,67
Interest Coverage -11,31 Asset Turnover 0,59
Working Capital 6,10 M Tangible Book Value 5,40 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,18 Forward P/E N/A
P/B Ratio 0,51 P/S Ratio 0,57
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -171,94%
Market Cap 2,76 M Enterprise Value 1,64 M
Per Share
EPS (Diluted TTM) -1,71 Revenue / Share 2,36
FCF / Share -2,30 OCF / Share -2,30
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion 202,61%
SBC-Adj. FCF -5,11 M Growth Momentum 4,29

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4,86 M 5,05 M 5,33 M 9,96 M 6,78 M
Net Income -2,34 M -7,04 M -13,98 M -15,38 M -14,66 M
EPS (Diluted) -1,71 -5,17 — -25,65 —
Gross Profit — — — — —
Operating Income -2,50 M -3,65 M -13,94 M -18,82 M -35,53 M
EBITDA — — — — —
R&D Expenses 9.000,0 53.000,0 1,39 M 1,51 M 3,89 M
SG&A Expenses 7,00 M 9,64 M 14,51 M 18,05 M 22,94 M
D&A — — — — —
Interest Expense 221.000,0 782.000,0 695.000,0 289.000,0 20.000,0
Income Tax 8.000,0 8.000,0 8.000,0 14.000,0 2.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6,55 M 13,52 M 19,71 M 28,92 M 43,92 M
Total Liabilities 2,41 M 7,29 M 7,00 M 8,02 M 12,72 M
Shareholders' Equity 4,14 M 6,22 M 12,84 M 21,03 M 31,09 M
Total Debt — — — — 0,0
Cash & Equivalents 259.000,0 4,24 M 6,52 M 20,64 M 28,69 M
Current Assets 6,36 M 9,24 M 14,97 M 25,40 M 35,39 M
Current Liabilities 2,06 M 2,56 M 3,59 M 4,21 M 5,04 M